Mr. Speaker, you were listening when I spoke earlier and I am sure that you heard me very clearly. First, we are planning to conduct research. In fact, research is already being conducted to see exactly how this product could be used as a pharmaceutical drug.
As I mentioned, we know that, at this point, it has still not been approved as a pharmaceutical drug anywhere in the world.
As regards the issue of compassion, there are terminally ill patients who tell us that they can benefit from this product. This is why they want a special authorization to obtain or grow this product. But we are talking about a very limited number of people, and this is why we said that we must continue to conduct research before opening the door to everyone.
I hope this alleviates the hon. member's concerns.